Can-Fite completes direct public offering

Can-Fite BioPharma Ltd. (Tel Aviv:CFBI; NYSE-M:CANF), Petah Tikva, Israel Business: Cancer, Infectious, Autoimmune Date completed: 2014-12-02 Type: Direct public offering Raised: $8 million Shares: 1....